According to a new market report published by Lucintel, the future of the primary cell culture market looks promising with opportunities in various applications, such as tissue culture & tissue engineering, vaccine production, gene therapy & regenerative medicine, toxicity testing & drug screening, cancer research, model system, virology, prenatal diagnosis, and stem cell therapy. The global primary cell culture market is expected to grow with a CAGR of 11% from 2020 to 2025. The major drivers for this market are rising research activities related to cancer, increasing demand for monoclonal antibodies, and growing biotechnology & biopharmaceutical industries.
To download report brochure, please go to https://www.lucintel.com/primary-cell-market.aspx and click "download brochure" tab from the menu
Primary cell culture refers to the disassociation of cells from a parental animal or plant tissue with the help of enzymatic or mechanical measures and maintaining the growth of cells in a glass or plastic containers under controlled environmental conditions. In this market, primary cell, reagents and supplements, and media are the major products. Lucintel forecasts that media will remain the largest product segment over the forecast period due to increasing research activities related to cancer.
North America will remain the largest region over the forecast period due to the introduction of automated culture techniques and increasing usage of advanced therapies in the region.
Thermo Fisher Scientific, Merck, Lonza, Promocell, GE Healthcare, Fujifilm Irvine Scientific, Corning, MatTek, Axol Bioscience, and ATCC are among the major suppliers in the global primary cell culture market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global primary cell culture market by product, separation and culture technique, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Primary Cell Culture Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global primary cell culture market by product, separation and culture technique, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Primary Cell
Fat Cells
Blood Cells
Nerve Cells
Endothelial Cells
Skin Cells
Stem Cells
Others
Reagents and Supplements
Attachment Solutions
Buffers and Salts
Freezing Media
Sera
Growth Factors and Cytokines
Others
Media
Fat Cells Media
Blood Cells Media
Nerve Cells Media
Endothelial Cells Media
Skin Cells Media
Stem Cells Media
Others
By Separation and Culture Technique [Value ($ Million) shipment analysis for 2014 – 2025]:
Explant Method
Enzymatic Disaggregation
Trypsin
Collagenase
Protease
Pronase
Dispase
Hyaluronidase
Neuraminidase
Others
Mechanical Separation
Others
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Tissue Culture & Tissue Engineering
Vaccine Production
Gene Therapy and Regenerative Medicine
Toxicity Testing and Drug Screening
Cancer Research
Virology
Stem Cell Therapy
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.